Smoking and COVID-19

Abstract

It is known that SARS-CoV-2 affects the respiratory tract and causes pneumonia and respiratory failure in patients. Smoking increases susceptibility to many respiratory diseases, including infections, and affects the prognosis and mortality of these diseases. The increased levels of angiotensin converting enzyme-2, which is a binding receptor for SARS-CoV-2 in the lungs, suggest that smoking has negative effects on patients with COVID-19. In this review, the relationship between smoking and COVID-19 is examined with a review of current literature. (English) [ABSTRACT FROM AUTHOR] SARS-CoV-2'nin solunum yollarini etkiledigi ve hastalarda pnomoni ve solunum yetmezligine neden oldugu bilinmektedir. Sigara icmek enfeksiyonlar dahil bircok solunum yolu hastaligina yatkinligi artirmakta ve bu hastaliklarin prognozunu ve olum oranini etkilemektedir. Akcigerlerde SARS-CoV-2 icin baglanma yeri oldugu bildirilen anjiyotensin donusturucu enzim2'nin artan seviyeleri, sigaranin COVID-19 hastaligi uzerinde olumsuz etkileri oldugunu dusundurmektedir. Bu derlemede, sigara ve COVID-19 arasindaki iliski, mevcut literaturle birlikte incelenmistir. (Turkish) [ABSTRACT FROM AUTHOR] Copyright of Respiratory Case Reports is the property of LookUs Scientific and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)